BMO raises DuPont stock price target to $190 on execution strength

BMO Capital raised DuPont's (NYSE:DD) price target to $190 from $186, citing strong execution and growth. The company reported Q3 adjusted earnings of $2.09 per share on $1.9B revenue, exceeding guidance. UBS and Wells Fargo also raised their targets, noting margin strength and increased EBITDA estimates.

Original reporting
Published Nov 9, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 2:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$DD
Bullish
high confidence
Mentioned
$DD
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$DDBullishMed
01

Why it matters

Analyst upgrades reinforce bullish bias; price may test higher levels.

02

Market read

Analyst target hikes suggest near-term upside for DD.

03

What to watch

Potential headwinds from raw material costs and macro slowdown.

Relevance 7/10Novelty 7/10Timing: today

Background

DuPont reported Q3 earnings beat and raised full-year outlook, prompting multiple analyst target upgrades.

Company-level read

Ticker impact

$DDBullishHigh confidence
Context

BMO Capital raised DuPont's price target to $190 from $186, citing execution strength and margin improvements.

Expected impact

likely upward pressure as investors price in the higher target.

Evidence & confidence

Target raise reflects improved outlook; market may bid the stock higher.

Market effects

May boost sentiment in specialty chemicals and materials sector.

U.S. market focus; limited regional spillover.

Modest, confined to investors tracking DuPont and peers.

Counterpoint

Target raise could be premature if margin gains stall.

Key entities

  • DuPont de Nemours Inc.

    Specialty chemicals manufacturer.

  • BMO Capital

    Raised price target to $190.

Related articles

$DDMed

Wells Fargo raises DuPont stock price target to $170 on valuation

Wells Fargo raised its price target for DuPont (NYSE:DD) to $170 from $166, maintaining an Overweight rating. The firm cites a higher-quality portfolio and a 2027 EV/EBITDA multiple of 13x. DuPont reported Q3 earnings of $2.09 per share on $1.9B revenue, a 4% increase. UBS also raised its target to $182, citing margin strength. Shares trade at $150.73, with potential upside to $170.

$DDHighAI 9/10

What Just Happened To DuPont Stock?

DuPont (DD) stock rose 8.6% on November 3, 2026, after reporting Q3 2026 earnings of $2.09 per share, beating estimates of $1.87. Sales reached $1.9B, up 4% YoY. The company raised its full-year guidance to $7.50 EPS and $7.19B in sales. Management cited strong order growth but delayed some Middle East projects to 2027. Most peers fell, with only Celanese rising 5.0%.

$DDHighAI 9/10

DuPont de Nemours Q3 Earnings Call Highlights

DuPont (NYSE: DD) reported Q3 Diversified Industrials operating EBITDA up 11% to $242M, with a 24.1% margin. The company highlighted productivity gains, AI initiatives, and raised its 2026 outlook to $7.19B in net sales and $1.785B in EBITDA. Q4 projections include $1.825B in net sales and $455M in EBITDA. DuPont also announced share repurchases and M&A plans.

$DDHighAI 9/10

Why DuPont Stock Trounced the Market on Tuesday

DuPont (DD) reported Q3 2026 earnings, with net sales rising 4% YoY to $1.87B and GAAP net income up 68% to $171M. Adjusted EPS of $2.09 beat estimates. The company raised its 2026 adjusted EPS guidance to $7.47-$7.52. DD stock closed up 8.61% on the news.